Skip to content

Randomized Controlld Trial of Dementia Education Resources for Action

Evaluation of Dementia Education and Resources for Action

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07545577
Acronym
DERA
Enrollment
100
Registered
2026-04-22
Start date
2026-06-16
Completion date
2027-08-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease and Related Dementia

Keywords

Community Health Workers, ADRD, Self-efficacy, Stigma, Digital Health Intervention

Brief summary

The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.

Interventions

BEHAVIORALDERA Online Training Program

The Dementia Education and Resources for Action (DERA) program is a structured, online training intervention designed for community health workers. The program consists of approximately 7 sessions delivered through a web-based platform. Content includes dementia fundamentals, early signs and risk factors, stigma reduction, and strategies for communication, support, and service navigation. The training incorporates video-based instruction, interactive materials, and quizzes to support learning and engagement.

Sponsors

George Mason University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years or older * Currently working as a community health worker or serving in a community health worker-related role * Able to read and understand English * Has access to the internet and a computer, tablet, or smartphone to complete the online training and surveys * Willing and able to provide informed consent

Exclusion criteria

* Previously completed the DERA training program * Unable to complete study procedures in English * Unable to access the online training platform or study surveys

Design outcomes

Primary

MeasureTime frameDescription
Dementia KnowledgeBaseline to post-intervention (approximately 6-8 weeks)Dementia knowledge will be assessed using the Dementia Knowledge Assessment Scale (DKAS). The DKAS is a validated instrument that measures knowledge across multiple domains, including causes, symptoms, risk factors, and care considerations. DKAS-25 total score ranges from 0 to 50. Items are scored 0-2, with higher scores indicating greater dementia-related knowledge.

Secondary

MeasureTime frameDescription
Dementia-Related StigmaBaseline to post-intervention (approximately 6-8 weeks)Dementia-related stigma will be assessed using an adapted 8-item stigma scale with response options ranging from strongly disagree to strongly agree. Total scores range from 8 to 40, with higher scores indicating greater dementia-related stigma.
Self-Efficacy in Dementia CareBaseline to post-intervention (approximately 6-8 weeks)Self-efficacy will be measured using a study-specific Community Health Worker Dementia Role Self-Efficacy Scale assessing confidence in performing dementia-related tasks, including education, communication, support, and service navigation. Response options range from "Not at all confident" to "Extremely confident." Total scores range from 8 to 40, with higher scores indicating greater self-efficacy in dementia-related service delivery.

Countries

United States

Contacts

CONTACTAlicia Hong
yhong22@gmu.edu7039931929

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026